title: Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
authors.affiliation: Services d'Anesthésie et de Chirurgie cardiaque, Centre Hospitalier Universitaire Trousseau et Université François Rabelais, Tours, France.
authors.forename: Marc Antoine
authors.initials: MA
authors.lastname: May
authors.forename: Yves
authors.initials: Y
authors.lastname: Gruel
authors.forename: Laurent
authors.initials: L
authors.lastname: Fauchier
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000601:surgery*; D001562:Benzimidazoles / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin